ロード中...
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells
Induction of neoangiogenesis is a hallmark feature during disease progression of hepatocellular carcinoma (HCC). Antiangiogenetic compounds represent a mainstay of therapeutic approaches; however, development of chemoresistance is observed in the majority of patients. Recent findings suggest that tu...
保存先:
主要な著者: | , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Wiley
2022-05-01
|
シリーズ: | Hepatology Communications |
オンライン・アクセス: | https://doi.org/10.1002/hep4.1869 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|